The Latest
Roche’s Collaborator MediLink Announces Phase III Data For Tam-Peli Showing Significantly Improved Overall Survival In Chinese Patient Population With Relapsed Small-cell Lung Cancer
MediLink announces phase III results showing improved survival for Tam-Peli in Chinese relapsed small-cell lung cancer patients, a potential breakthrough.